DNA methylation signature and clinical delineation of PACS1-related disorder in 24 unreported individuals
- 25 March 2026
- journal article
- research article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 34 (6) , 759-768
Abstract
PACS1-related disorder (PACS1-RD), also known as Schuurs-Hoeijmakers syndrome, is a rare autosomal dominant neurodevelopmental disorder predominantly caused by the recurrent de novo c.607 C > T p.(Arg203Trp) gain-of-function variant. Although core clinical features have been delineated, systematic data on developmental milestones, growth parameters, and clinical variability remain limited. We assembled a series of 24 previously unreported, unrelated individuals with PACS1-RD and compared their clinical and molecular features with 84 individuals from the literature. Genome-wide DNA methylation profiling was performed on peripheral blood DNA using bisulfite sequencing, interrogating ~860,000 CpG sites. Our study expands the phenotypic spectrum of PACS1-RD by reporting median age at independent walking and first spoken words (both 24 months), cross-sectional growth parameters, and previously undescribed clinical features, including congenital kidney malformations (25%) and feeding difficulties (75%). Compared with the literature, our series showed a higher prevalence of cryptorchidism (77.8%), congenital heart defect (45.8%), and hypotonia (75%). Methylation analysis identified a specific episignature for PACS1-RD, consistently observed in individuals carrying either the canonical p.(Arg203Trp) or the non-recurrent p.(Arg203Gln) variant. This episignature further enabled PACS1-RD diagnosis in one unsolved individual initially suspected of Kabuki syndrome. These findings refine the clinical delineation of PACS1-RD and establish an episignature that will support diagnosis in unresolved neurodevelopmental disorders and guide pathogenicity assessment of non-recurrent PACS1 variants.Keywords
This publication has 40 references indexed in Scilit:
- Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental DisordersThe American Journal of Human Genetics, 2021
- Prenatal and postnatal diagnosis of Schuurs‐Hoeijmakers syndrome: Case series and review of the literatureAmerican Journal of Medical Genetics Part A, 2020
- Overview of Specifications to the ACMG/AMP Variant Interpretation GuidelinesCurrent Protocols in Human Genetics, 2019
- Diagnostic Utility of Genome-wide DNA Methylation Testing in Genetically Unsolved Individuals with Suspected Hereditary ConditionsThe American Journal of Human Genetics, 2019
- Schuurs‐Hoeijmakers syndrome in a patient from IndiaAmerican Journal of Medical Genetics Part A, 2019
- Schuurs‐Hoeijmakers syndrome in two patients from JapanAmerican Journal of Medical Genetics Part A, 2018
- Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental SyndromesThe American Journal of Human Genetics, 2018
- Clinical delineation of the PACS1‐related syndrome—Report on 19 patientsAmerican Journal of Medical Genetics Part A, 2016
- Recurrent De Novo Mutations in PACS1 Cause Defective Cranial-Neural-Crest Migration and Define a Recognizable Intellectual-Disability SyndromeThe American Journal of Human Genetics, 2012
- Calcium signaling in lymphocytesCurrent Opinion in Immunology, 2008